Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04950608 · ClinicalTrials.gov registry record · Phase 2
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
A Phase 2 study of Cancer-related Problem/Condition and Psychotherapy, sponsored by Yvan Beaussant, MD, MSci.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT04950608: Completed Phase 2 study of Cancer-related Problem/Condition and Psychotherapy, sponsored by Yvan Beaussant, MD, MSci.
NCT04950608 is a Phase 2 study of Cancer-related Problem/Condition and Psychotherapy that has completed, run by Yvan Beaussant, MD, MSci. The registered enrollment target is 15 participants, below the 112-participant average among 10 other Cancer-related Problem/Condition trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04950608, a Phase 2 study of Cancer-related Problem/Condition and Psychotherapy, has completed, sponsored by Yvan Beaussant, MD, MSci.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective of this study is to develop and pilot test a novel regimen of psilocybin-assisted psychotherapy for demoralization in patients receiving hospice care. -The name of the study drug involved in this study is Psilocybin
Primary Outcome
This measurement will assess enrollment feasibility based on the screening log.
Conditions Studied
Interventions
- BEHAVIORAL Psychotherapy
- DRUG Psilocybin
Study Locations (1)
Massachusetts
- Care Dimensions - Danvers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-03-09 |
| Est. Completion | 2025-12-31 |
| Phase | Phase 2 |
What the finished NCT04950608 record still lists
NCT04950608 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 112-participant average among 10 other Cancer-related Problem/Condition trials with a reported enrollment target (87% lower).
The record links to 8 conditions, with Cancer-related Problem/Condition appearing as the primary indexed condition, and to 2 interventions - of which Psychotherapy is the first listed.
NCT04950608 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04950608 about?
NCT04950608 is a clinical study titled "Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care". The overall objective of this study is to develop and pilot test a novel regimen of psilocybin-assisted psychotherapy for demoralization in patients receiving hospice care. -The name of the study drug involved in this study is Psilocybin
What is the current status of trial NCT04950608?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2022-03-09. Estimated completion is 2025-12-31.
What conditions does trial NCT04950608 study?
This clinical trial studies the following conditions: Cancer-related Problem/Condition, Psychotherapy, Hospice, Terminal Illness, Demoralization.
What interventions are being tested in trial NCT04950608?
The interventions under investigation include: Psychotherapy (BEHAVIORAL), Psilocybin (DRUG).
Who is sponsoring clinical trial NCT04950608?
This trial is sponsored by Yvan Beaussant, MD, MSci, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04950608 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer-related Problem/Condition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04950608's enrollment target sits among peer trials
15 10th of 10 higher than 1 of 10 other Cancer-related Problem/Condition trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer-related Problem/Condition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors
RECRUITING · NA
-
The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients
ACTIVE NOT RECRUITING · NA
-
Virtual Exercise Program to Reduce Cancer Related Fatigue
ACTIVE NOT RECRUITING · NA
-
Systematic Light Exposure for Fatigue in Breast Cancer Patients
COMPLETED · NA
-
Programmed Environmental Illumination (PEI) of Hospital Rooms to Prevent/Reduce Cancer-Related Fatigue
COMPLETED · NA
-
Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer Survivors
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI